- Home
- ALVO vs DKL Comparison
ALVO vs DKL Comparison
Compare ALVO & DKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVO
- DKL
- Stock Information
- Founded
- ALVO 2013
- DKL 2012
- Country
- ALVO Luxembourg
- DKL United States
- Employees
- ALVO N/A
- DKL N/A
- Industry
- ALVO Biotechnology: Pharmaceutical Preparations
- DKL Natural Gas Distribution
- Sector
- ALVO Health Care
- DKL Energy
- Exchange
- ALVO Nasdaq
- DKL Nasdaq
- Market Cap
- ALVO 2.5B
- DKL 2.3B
- IPO Year
- ALVO N/A
- DKL N/A
- Fundamental
- Price
- ALVO $9.35
- DKL $43.08
- Analyst Decision
- ALVO Buy
- DKL Buy
- Analyst Count
- ALVO 1
- DKL 4
- Target Price
- ALVO $18.00
- DKL $44.25
- AVG Volume (30 Days)
- ALVO 229.9K
- DKL 129.4K
- Earning Date
- ALVO 08-14-2025
- DKL 08-05-2025
- Dividend Yield
- ALVO N/A
- DKL 10.30%
- EPS Growth
- ALVO N/A
- DKL 7.97
- EPS
- ALVO 0.34
- DKL 2.98
- Revenue
- ALVO $587,890,000.00
- DKL $938,491,000.00
- Revenue This Year
- ALVO $35.07
- DKL $21.19
- Revenue Next Year
- ALVO $44.61
- DKL N/A
- P/E Ratio
- ALVO $27.70
- DKL $14.34
- Revenue Growth
- ALVO 413.92
- DKL N/A
- 52 Week Low
- ALVO $7.35
- DKL $34.59
- 52 Week High
- ALVO $13.79
- DKL $45.71
- Technical
- Relative Strength Index (RSI)
- ALVO 41.18
- DKL 58.70
- Support Level
- ALVO $10.32
- DKL $42.34
- Resistance Level
- ALVO $11.85
- DKL $44.14
- Average True Range (ATR)
- ALVO 0.46
- DKL 0.81
- MACD
- ALVO -0.23
- DKL -0.02
- Stochastic Oscillator
- ALVO 19.87
- DKL 63.32
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
About DKL Delek Logistics Partners L.P. Common Units representing Limited Partner Interests
Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes gathering and processing; wholesale marketing and terminalling; storage and transportation and investment in pipeline joint ventures. It generates maximum revenue from the wholesale marketing and terminalling segment, which provides marketing services for the refined products output of the Delek Holdings' refineries, engages in wholesale activity at its terminals and terminals owned by third parties, whereby it purchases light product for sale and exchange to third parties, and provides terminalling services at its refined products terminals to independent third parties and Delek Holdings.